🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tia H. Turner

Virginia Commonwealth University

ORCID: 0000-0002-6284-4933
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models”.

Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models

PNAS Nexus(2022)10.1093/pnasnexus/pgac232
N/A
0.482DataRank · unranked
10 citations

Tia H. Turner, Jinyang Cai, Konstantinos V. Floros, Ann K. Yu, Colin M. Coon +15 more

Exploitation of sulfated glycosaminoglycan status for precision medicine of platinums in triple-negative breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.05.442616
N/A
0DataRank · unranked
0 citations

Erica J. Peterson, Samantha J. Katner, Tia H. Turner, Mohammad A. Alzubi, J. Chuck Harrell +13 more

Genomic screening reveals UBA1 as a potent and druggable target in c-MYC-high TNBC models

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.17.491908
N/A
0DataRank · unranked
0 citations

Tia H. Turner, Jinyang Cai, Konstantinos V. Floros, Ann K. Yu, Colin M. Coon +15 more

Data from Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast Cancer

(2023)10.1158/1535-7163.c.6543516
N/A
0DataRank · unranked
0 citations

Erica J. Peterson, Samantha J. Katner, Tia H. Turner, Mohammad A. Alzubi, J. Chuck Harrell +14 more